← All organizations

Highest phase reached
Phase 3
Timeline
Drugs by trial phase (12 distinct, 30 trials)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Indications
Marketed drugs (1)
Recent trials (36)
- NCT05979415Lead sponsorPhase 2Sep 30, 2023
- NCT04645953Lead sponsorPhase 2Dec 15, 2020
- NCT04327765Lead sponsorPhase 1Mar 10, 2020
- NCT04200092Lead sponsorPhase 1Nov 4, 2019
- NCT04157933Lead sponsorPhase 1Oct 16, 2019
- NCT03822364Lead sponsorPhase 1Nov 26, 2018
- NCT02351115Lead sponsorPhase 2Jan 1, 2015
- NCT01877642Lead sponsorPhase 1Jun 1, 2013
- NCT01854710Lead sponsorPhase 1May 1, 2013
- NCT00889837Study directorPhase 1Jun 1, 2009
- NCT00889837Lead sponsorPhase 1Jun 1, 2009
- NCT00890175Lead sponsorPhase 1May 1, 2009
- NCT00890175Study directorPhase 1May 1, 2009
- NCT00873769Lead sponsorPhase 1Apr 1, 2009
- NCT00874237Lead sponsorPhase 1Apr 1, 2009
Details
- Founded
- Mountain View, CA, US Jan 1, 2000
- Last known activity
- Sep 30, 2023